Kyntra Bio (KYNB) Receivables - Other (2016 - 2024)
Historic Receivables - Other for Kyntra Bio (KYNB) over the last 11 years, with Q4 2024 value amounting to $28.5 million.
- Kyntra Bio's Receivables - Other changed 0.0% to $28.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $28.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $28.5 million for FY2024, which is 0.0% changed from last year.
- According to the latest figures from Q4 2024, Kyntra Bio's Receivables - Other is $28.5 million, which was down 0.0% from $28.5 million recorded in Q3 2024.
- In the past 5 years, Kyntra Bio's Receivables - Other registered a high of $38.8 million during Q1 2022, and its lowest value of $3.7 million during Q1 2020.
- Moreover, its 5-year median value for Receivables - Other was $17.1 million (2022), whereas its average is $18.7 million.
- Its Receivables - Other has fluctuated over the past 5 years, first tumbled by 9670.39% in 2020, then soared by 78227.24% in 2021.
- Over the past 5 years, Kyntra Bio's Receivables - Other (Quarter) stood at $4.1 million in 2020, then skyrocketed by 164.84% to $10.9 million in 2021, then rose by 10.59% to $12.1 million in 2022, then skyrocketed by 135.77% to $28.5 million in 2023, then changed by 0.0% to $28.5 million in 2024.
- Its Receivables - Other was $28.5 million in Q4 2024, compared to $28.5 million in Q3 2024 and $28.5 million in Q2 2024.